# Clinical Therapeutic Potential of Novel Microbiome LP-51 on Xerosis Individual Based on Xerosis-microbiome Index

> **NCT06706050** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ho-Yeon Song** · enrollment: 43 (actual)

## Conditions studied

- Xerosis

## Interventions

- **BIOLOGICAL:** Microbiome Therapeutic LP-51
- **OTHER:** placebo cream (M23004-03)

## Key facts

- **NCT ID:** NCT06706050
- **Lead sponsor:** Ho-Yeon Song
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-08
- **Primary completion:** 2023-06-16
- **Final completion:** 2023-11-06
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2024-11-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06706050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06706050, "Clinical Therapeutic Potential of Novel Microbiome LP-51 on Xerosis Individual Based on Xerosis-microbiome Index". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06706050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*